CS
THRN

Credit Suisse’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Credit Suisse’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$4 – 3860
2022
Q4 		$4 Sell
1
-75
-99% -$333 ﹤0.01% 3853
2022
Q3 		$0 Buy
76
+59
+347% +$297 ﹤0.01% 4424
2022
Q2 		$0 Buy
+17
New +$103 ﹤0.01% 4485

Other funds holding THRN

EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse's THRN Position: Q1 2023 in Review

Credit Suisse sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q1 2023, closing a stake of 1 share — an estimated $4 sold.

Credit Suisse first reported a position in THRN in Q2 2022 and held it in 3 quarters. The position peaked at $4 in Q4 2022. 44 funds tracked by Wall St. Rank hold THRN as of Q1 2023.

  • Credit Suisse reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 1 Thorne Healthtech, Inc. Common Stock share in Q1 2023, an estimated $4.
  • Credit Suisse first reported a position in Thorne Healthtech, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Credit Suisse's Thorne Healthtech, Inc. Common Stock position peaked at $4 in Q4 2022.
  • 44 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.